METHOD AND TOOL FOR PREDICTING CANCER AND OTHER DISEASES
    1.
    发明申请
    METHOD AND TOOL FOR PREDICTING CANCER AND OTHER DISEASES 有权
    预防癌症和其他疾病的方法和工具

    公开(公告)号:US20100098705A1

    公开(公告)日:2010-04-22

    申请号:US12520718

    申请日:2007-12-12

    摘要: The invention concerns a marker for low-grade inflammation and metabolic syndrome (MS) and MS-related diseases and/or low-grade inflammation-related diseases such as cardiovasculardisease, ischemic heart disease and type 2 diabetes. More particularly it concerns the measurement of the concentration of soluble urokinase plasminogen activator receptor (suPAR) in human biological fluids (sputum, cystic fluid, ascites, serum, plasma, urine) as a tool of diagnosing and/or prognosticating low-grade inflammation and metabolic syndrome and the risk of development of the related diseases such as cancer, cardiovascular disease, ischemic heart disease and type 2 diabetes.

    摘要翻译: 本发明涉及低度炎症和代谢综合征(MS)和MS相关疾病和/或低度炎症相关疾病如心血管疾病,缺血性心脏病和2型糖尿病的标志物。 更具体地说,它涉及测量人体生物液体(痰液,囊性液体,腹水,血清,血浆,尿液)中可溶性尿激酶纤溶酶原激活物受体(suPAR)的浓度,作为诊断和/或预测低度炎症的工具, 代谢综合征和相关疾病如癌症,心血管疾病,缺血性心脏病和2型糖尿病发展的风险。

    Method for predicting cancer and other diseases
    2.
    发明授权
    Method for predicting cancer and other diseases 有权
    预测癌症等疾病的方法

    公开(公告)号:US08815519B2

    公开(公告)日:2014-08-26

    申请号:US12520718

    申请日:2007-12-12

    IPC分类号: G01N33/53

    摘要: The invention concerns a marker for low-grade inflammation and metabolic syndrome (MS) and MS-related diseases and/or low-grade inflammation-related diseases such as cardiovasculardisease, ischemic heart disease and type 2 diabetes. More particularly it concerns the measurement of the concentration of soluble urokinase plasminogen activator receptor (suPAR) in human biological fluids (sputum, cystic fluid, ascites, serum, plasma, urine) as a tool of diagnosing and/or prognosticating low-grade inflammation and metabolic syndrome and the risk of development of the related diseases such as cancer, cardiovascular disease, ischemic heart disease and type 2 diabetes.

    摘要翻译: 本发明涉及低度炎症和代谢综合征(MS)和MS相关疾病和/或低度炎症相关疾病如心血管疾病,缺血性心脏病和2型糖尿病的标志物。 更具体地说,它涉及测量人体生物液体(痰液,囊性液体,腹水,血清,血浆,尿液)中可溶性尿激酶纤溶酶原激活物受体(suPAR)的浓度,作为诊断和/或预测低度炎症的工具, 代谢综合征和相关疾病如癌症,心血管疾病,缺血性心脏病和2型糖尿病发展的风险。